Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2024 Dec 24;17(1):4.
doi: 10.3390/cancers17010004.

Recurrent Sinonasal Squamous Cell Carcinoma: Current Insights and Treatment Advances

Meryl B Kravitz  1   2 , Vivek Annadata  3 , Benjamin Ilyaev  3 , Charles C L Tong  1 , Judd H Fastenburg  1 , Mark B Chaskes  1
Affiliations
Review

Recurrent Sinonasal Squamous Cell Carcinoma: Current Insights and Treatment Advances

Meryl B Kravitz et al. Cancers (Basel). .

Abstract

Squamous cell carcinoma is the most common malignancy affecting the sinonasal tract. Local recurrence is the main pattern of treatment failure, affecting nearly half of patients treated for primary sinonasal squamous cell carcinoma (SNSCC). Due to disease rarity and heterogeneity of practices, there are limited guidelines for how to diagnose and care for these patients. This paper reviews current evidence regarding etiology, pathophysiology, diagnosis, prognostic factors, and treatment modalities of recurrent SNSCC (rSNSCC). Currently, salvage surgery offers the only durable approach for eligible patients. These resections often require robust reconstructive options due to prior surgery or radiation. Chemoradiation is offered as an adjuvant or palliative approach when surgery is not a feasible option. Emerging options such as immunotherapy and particle therapy remain an area of ongoing investigation.

Keywords: endoscopic; open; recurrence; sinonasal; squamous cell carcinoma; tumor.

PubMed Disclaimer

Conflict of interest statement

None of the authors have any disclosures.

Figures

Figure 1
Figure 1
Recurrent sinonasal squamous cell carcinoma—proposed treatment algorithm.
See this image and copyright information in PMC

References

    1. Ferrari M., Taboni S., Carobbio A.L.C., Emanuelli E., Maroldi R., Bossi P., Nicolai P. Sinonasal Squamous Cell Carcinoma, a Narrative Reappraisal of the Current Evidence. Cancers. 2021;13:2835. doi: 10.3390/cancers13112835. - DOI - PMC - PubMed
    1. Kacorzyk U., Rutkowski T.W. The Role of Salvage in the Management of Patients with Sinonasal Squamous Cell Carcinoma. Biomedicines. 2022;10:1266. doi: 10.3390/biomedicines10061266. - DOI - PMC - PubMed
    1. Orlandi E., Cavalieri S., Granata R., Nicolai P., Castelnuovo P., Piazza C., Schreiber A., Turri-Zanoni M., Quattrone P., Miceli R., et al. Locally Advanced Epithelial Sinonasal Tumors: The Impact of Multimodal Approach. Laryngoscope. 2020;130:857–865. doi: 10.1002/lary.28202. - DOI - PubMed
    1. McMahon J.D., Wong L.S., Crowther J., Taylor W.M., McManners J., Devine J.C., Wales C., Maciver C. Patterns of Local Recurrence after Primary Resection of Cancers That Arise in the Sinonasal Region and the Maxillary Alveolus. Br. J. Oral Maxillofac. Surg. 2013;51:389–393. doi: 10.1016/j.bjoms.2012.09.018. - DOI - PubMed
    1. Kim S.A., Chung Y.-S., Lee B.J. Recurrence Patterns of Sinonasal Cancers after a 5-Year Disease-Free Period. Laryngoscope. 2019;129:2451–2457. doi: 10.1002/lary.27866. - DOI - PubMed

LinkOut - more resources